dobutamine has been researched along with nifedipine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (19.05) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Motley, ED; Nichols, AJ; Ruffolo, RR | 1 |
| Burkhoff, D; Sagawa, K; Sugiura, S; Yue, DT | 1 |
| Thoolen, MJ; Timmermans, PB | 1 |
| Burkhoff, D; Franz, MR; Oikawa, RY; Sagawa, K; Schaefer, J; Yue, DT | 1 |
| Eigenmann, R; Gerold, M; Wolfgang, H | 1 |
| Coetzee, A; Genade, S; Harper, I; Hattingh, P; Lochner, A | 1 |
| Kojima, S; Parmley, WW; Wikman-Coffelt, J; Wu, ST | 1 |
| Abbott, J; Caputo, G; Schwartz, JB | 1 |
| Bruno, G; Cordovil, A; Dodi, C; Picano, E; Pingitore, A; Sicari, R | 1 |
| Taherzadeh, M; Warren, JB | 1 |
| Artemiou, O; Bîrsan, T; Klepetko, W; Kranz, A; Mares, P; Taghavi, S; Zuckermann, A | 1 |
| Ito, T; Miyake, T; Taki, K | 1 |
| Li, H; Lu, D; Lv, X; Wang, H; Wang, Y; Yang, D; Yu, X | 1 |
1 review(s) available for dobutamine and nifedipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for dobutamine and nifedipine
| Article | Year |
|---|---|
Early experience with dobutamine stress testing and cardiac cine-tomographic imaging in the elderly: antianginal effects of nifedipine-GITS.
Topics: Age Factors; Angina Pectoris; Cineradiography; Coronary Angiography; Coronary Disease; Dobutamine; Double-Blind Method; Drug Delivery Systems; Edema; Exercise Test; Female; Gastrointestinal Transit; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Nifedipine; Peripheral Vascular Diseases; Rest; Tomography, X-Ray Computed | 1993 |
Effects of antianginal therapy with a calcium antagonist and nitrates on dobutamine-atropine stress echocardiography. Comparison with exercise electrocardiography.
Topics: Atropine; Calcium Channel Blockers; Cardiotonic Agents; Coronary Disease; Diltiazem; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Exercise Test; Female; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Nitrates; Parasympatholytics; Prospective Studies; Vasodilator Agents | 1997 |
18 other study(ies) available for dobutamine and nifedipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
The effect of pertussis toxin on alpha 1-adrenoceptor-mediated vasoconstriction by the full agonist, cirazoline, and the partial agonist, (-)-dobutamine, in pithed rats.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Blood Vessels; Body Weight; Calcium Channels; Dobutamine; Dose-Response Relationship, Drug; GTP-Binding Proteins; Imidazoles; Male; Nifedipine; Pertussis Toxin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Vasoconstrictor Agents; Virulence Factors, Bordetella | 1991 |
Contractility-dependent curvilinearity of end-systolic pressure-volume relations.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Coronary Circulation; Dobutamine; Dogs; Mathematics; Models, Cardiovascular; Myocardial Contraction; Nifedipine; Ventricular Function | 1987 |
Equal potency of nifedipine to inhibit alpha 1-(dobutamine and BDF 6143) and alpha 2-adrenoceptor (B-HT 920) induced pressor responses in pithed rats; lack of effect of phenoxybenzamine.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Blood Pressure; Decerebrate State; Dobutamine; Dose-Response Relationship, Drug; Imidazoles; Isoindoles; Male; Nifedipine; Phenoxybenzamine; Rats; Rats, Inbred Strains | 1987 |
Influence of ventricular contractility on non-work-related myocardial oxygen consumption.
Topics: Animals; Dobutamine; Dogs; Heart; Myocardial Contraction; Nifedipine; Oxygen Consumption | 1987 |
Telemetry of cardiac left ventricular pressure in conscious dogs.
Topics: Animals; Dobutamine; Dogs; Heart Ventricles; Myocardial Contraction; Nifedipine; Pressure; Telemetry; Ventricular Function; Verapamil | 1981 |
Effects of beta-blockers and Ca(2+)-antagonists on the response of the isolated working rat heart to adrenergic stimulants after cardioplegic arrest.
Topics: Adenine Nucleotides; Animals; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Epinephrine; Heart; Heart Arrest, Induced; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Reperfusion; Myocardium; Nifedipine; Propranolol; Rats; Rats, Wistar; Stimulation, Chemical | 1993 |
Relationship between intracellular calcium and oxygen consumption: effects of perfusion pressure, extracellular calcium, dobutamine, and nifedipine.
Topics: Animals; Calcium; Coronary Circulation; Diastole; Dobutamine; Fluorescent Dyes; Heart; Indoles; Myocardial Contraction; Myocardium; Nifedipine; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Systole; Ventricular Pressure | 1994 |
Cardiac inotropes inhibit the oedema caused by nifedipine in rabbit skin.
Topics: Animals; Bradykinin; Calcium Channel Blockers; Cardiotonic Agents; Dinoprostone; Dobutamine; Dopamine; Edema; Histamine; Isoproterenol; Male; Microcirculation; Nifedipine; Rabbits; Skin | 1997 |
Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension.
Topics: Adult; Alprostadil; Antihypertensive Agents; Cardiac Output, Low; Cardiotonic Agents; Catheterization, Swan-Ganz; Clonidine; Dobutamine; Echocardiography; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Transplantation; Male; Nifedipine; Respiratory Insufficiency; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 1999 |
[A case of successfully treated nifedipine-poisoning].
Topics: Calcium Channel Blockers; Cathartics; Charcoal; Dobutamine; Gastric Lavage; Humans; Isotonic Solutions; Male; Middle Aged; Nifedipine; Ringer's Lactate; Treatment Outcome | 2003 |
β₁-adrenoceptor stimulation promotes LPS-induced cardiomyocyte apoptosis through activating PKA and enhancing CaMKII and IκBα phosphorylation.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Apoptosis; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Caspases; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Endotoxemia; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Nifedipine; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, Adrenergic, beta-1 | 2015 |